| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fate Therapeutics Inc (FATE) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. FATE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.89M | $8.31M | - | |
| CEO | 1.30M | $2.78M | - | |
| Other | 400.0K | $854.0K | - | |
| Dir | 110.0K | $234.8K | - | |
| CFO | 100.0K | $213.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Wolchko J Scott87 | President And CEO | Sell | 45,907 | $5.24 | $240,552.68 | -10.6% | -0.2% | -16.8% | |
| Jan 10, 2023 | Valamehr Bahram87 | Chief R&D Officer | Sell | 10,917 | $5.24 | $57,205.08 | -6.1% | -0.2% | -16.8% | |
| Jan 10, 2023 | Tahl Cindy79 | General Counsel And Secretary | Sell | 11,553 | $5.24 | $60,537.72 | -6.1% | -0.2% | -16.8% | |
| Jan 10, 2023 | Plavsic Mark76 | Chief Technical Officer | Sell | 3,418 | $5.24 | $17,910.32 | -2.7% | -0.2% | -16.8% | |
| Jan 10, 2023 | Dulac Edward J III81 | Chief Financial Officer | Sell | 7,331 | $5.24 | $38,414.44 | -5.4% | -0.2% | -16.8% | |
| Jan 10, 2023 | Chu Yu-Waye72 | Chief Medical Officer | Sell | 7,825 | $5.24 | $41,003.00 | -5.2% | -0.2% | -16.8% | |
| Aug 18, 2022 | Dulac Edward J III81 | Chief Financial Officer | Sell | 5,135 | $29.81 | $153,051.37 | -1.8% | -32.0% | -90.8% | |
| Jul 22, 2022 | Wolchko J Scott87 | President And CEO | Sale+OE | 36,246 | $32.74 | $1,186,716.65 | -1.6% | -38.7% | -85.6% | |
| Jul 7, 2022 | Valamehr Bahram87 | Chief R&D Officer | Sale+OE | 17,158 | $30.23 | $518,686.34 | -8.7% | -23.8% | -84.6% | |
| Jul 6, 2022 | Valamehr Bahram87 | Chief R&D Officer | Sale+OE | 7,842 | $30.07 | $235,808.94 | -4.2% | -16.8% | -83.7% |